Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Reich

Showing results (161-170 of 218) with videos related to

Pageof 22
Sort By:
The British Journal of Dermatology|October 15, 2013
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomesM Augustin, C Blome, A Costanzo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 5, 2015
Patient-relevant needs and treatment goals in nail psoriasisC Blome, A Costanzo, E Dauden, et al.
The British Journal of Dermatology|May 18, 2006
Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trialK Reich, F O Nestle, K Papp, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 18, 2015
Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis surveyP C M van de Kerkhof, K Reich, A Kavanaugh, et al.
The British Journal of Dermatology|June 13, 2020
Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studiesA Blauvelt, C Paul, P van de Kerkhof, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 7, 2019
Efficacy of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials at weeks 12 and 28K A Papp, K Reich, A Blauvelt, et al.
Archives of Dermatological Research|April 7, 2016
The German National Program on Psoriasis Health Care 2005-2015: results and experiencesM Augustin, L Eissing, A Langenbruch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 13, 2016
Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasisM Augustin, C Blome, C Paul, et al.
The British Journal of Dermatology|June 4, 2010
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III studyR-M Szeimies, P Radny, M Sebastian, et al.
The British Journal of Dermatology|May 10, 2018
Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trialsA Blauvelt, K Reich, K A Papp, et al.
Pageof 22

Showing results (161-170 of 218) with videos related to

Sort By:
Pageof 22
The British Journal of Dermatology|October 15, 2013
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomesM Augustin, C Blome, A Costanzo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 5, 2015
Patient-relevant needs and treatment goals in nail psoriasisC Blome, A Costanzo, E Dauden, et al.
The British Journal of Dermatology|May 18, 2006
Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trialK Reich, F O Nestle, K Papp, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 18, 2015
Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis surveyP C M van de Kerkhof, K Reich, A Kavanaugh, et al.
The British Journal of Dermatology|June 13, 2020
Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studiesA Blauvelt, C Paul, P van de Kerkhof, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 7, 2019
Efficacy of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials at weeks 12 and 28K A Papp, K Reich, A Blauvelt, et al.
Archives of Dermatological Research|April 7, 2016
The German National Program on Psoriasis Health Care 2005-2015: results and experiencesM Augustin, L Eissing, A Langenbruch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 13, 2016
Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasisM Augustin, C Blome, C Paul, et al.
The British Journal of Dermatology|June 4, 2010
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III studyR-M Szeimies, P Radny, M Sebastian, et al.
The British Journal of Dermatology|May 10, 2018
Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trialsA Blauvelt, K Reich, K A Papp, et al.
Pageof 22